Ethyl chloride

PreclinicalSmall molecule

NNYU Langone Health

Ethyl chloride is one of 59 small molecule programs targeting Head and Neck. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Head and NeckCompleted

EffectivenessCompleted

AnesthesiaCompleted

Head and NeckPreclinical

Completed

EffectivenessPreclinical

Completed

AnesthesiaPreclinical

Completed

Competition

Competitive Landscape

76 competitors in Effectiveness

#DrugCompanyPhaseTrials

Kesimpta

Novartis

Phase 3

2 2

Mounjaro

Eli Lilly

Phase 3

1 3

Actos

Takeda

Phase 3

1 4

Elucirem

GGuerbet

Phase 3

1 5

Nicotine Free Cigarettes

Pfizer

Phase 3

3 6

Lidocain

Bayer

Phase 3

1 7

Botulinum Toxin a

GSK

Phase 3

1 8

Pneumococcal Conjugate Vaccine

Novartis

Phase 3

1 9

Droxia

TTheravia

Phase 2

9 10

Temodar

CCidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

Phase 2

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Effectiveness1 trial

Comparison of Effectiveness of Pre-cooling With Ethyl Chloride Versus Honey

Completed·—·N/A·NCT05568563·90 enrolled

Anesthesia1 trial

Ethyl Chloride Vapocoolant as Anesthesia for Arterial Punctures

Completed·BBionorte·N/A·NCT02587143·126 enrolled

Head and Neck1 trial

Topical Anaesthesia in Cutaneous Head and Neck Surgery

Completed·UUniversity Hospital Waterford·N/A·NCT06274905·124 enrolled

Shoulder pain1 trial

The Efficacy of Local Anesthetics to Reduce Shoulder Pain Post-Steroid Injections

Terminated·MMilton S. Hershey Medical Center·Phase 4·NCT02592629·19 enrolled

Propofol1 trial

the Effect of Spray on Propofol Injection Pain

Completed·TThe Catholic University of Korea·Phase 4·NCT02770690·90 enrolled

2 more indications

Pain1 trial

Comparison of Distraction Methods for Pain Relief of Trigger Finger Injection

Withdrawn·NNYU Langone Health·Phase 1·NCT03445780

Unspecified1 trial

Ethyl Chloride for NPWT

Completed·—·Phase 4·NCT04635696·100 enrolled

Sources

References

[1]
ClinicalTrials.gov — 7 trial records for Ethyl chloride. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Ethyl chloride compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Ethyl chloride. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — NYU Langone Health company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: NNYU Langone Health

Ethyl chloride

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Effectiveness1 trial

Anesthesia1 trial

Head and Neck1 trial

Shoulder pain1 trial

Propofol1 trial

Pain1 trial

Unspecified1 trial

References

Drug Info

Quick Facts

Related News